poisar

Stocks · News reference

Nutriband Receives USPTO Notice of Allowance for Lead Product Trademarks

Fiscal.ai

Nutriband Inc. announced it received a Notice of Allowance from the U.S. Patent and Trademark Office for commercial brand name trademarks related to its abuse-deterrent fentanyl transdermal system.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Globenewswire IncNa

    Nutriband Announces USPTO Notice of Allowance for Commercial Brand Name Trademarks for Its Abuse-Deterrent Fentanyl Transdermal System

    Nutriband Inc. received a USPTO Notice of Allowance for commercial brand name trademarks for its abuse-deterrent fentanyl transdermal patch incorporating AVERSA™ technology. The company is preparing preapproval regulatory submissions for the FDA, EMA, and international agencies, with peak annual U.S. sales potential estimated between $80-200 million.